Vimpat now on the PBS
Lacosamide, also sold under the brand name VIMPAT, is now listed on the Pharmaceutical Benefits Scheme (PBS). For more
Advances in epilepsy research will affect medication choices
Queensland researchers have turned blood samples from epilepsy patients into functioning human brain tissue, allowing them to test the effectiveness of different combinations of anti-seizure medications. Listen here
Heart Rate Variability as a SUDEP Biomarker
Recently, in the largest SUDEP biomarker study to date, senior author Orrin Devinsky, MD, and colleagues identified heart rate variability as a new biomarker for SUDEP. For more
Research reveals a common cause for seizures and memory problems in epilepsy
Damage to the temporal lobe can contribute to both memory problems and seizures in the most common form of epilepsy. For more
High blood pressure may increase risk for late-onset epilepsy
Hypertension is associated with an increased risk for developing epilepsy. For more
